Targeting inflammation to reduce 90-day and 1-year postoperative severe morbidity in patients with unfavorable inflammatory profile undergoing oncologic surgery (POST CARE Trial)
Not yet recruitingCTIS2024-515333-14-03
Fondazione IRCCS Istituto Nazionale Dei TumoriPatients scheduled for major surgery for oncologic indication
Target: 83Updated: 2025-12-17